DIFFERENCES IN SERUM INTERLEUKIN-6 (IL-6) BETWEEN HEALTHY DEXTRAL AND NON-DEXTRAL SUBJECTS

被引:0
|
作者
CHENGAPPA, KNR
GANGULI, R
YANG, ZW
SCHURIN, G
BRAR, JS
ROSENBLEET, JA
RABIN, BS
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,DIV IMMUNOPATHOL,PITTSBURGH,PA
[2] UNIV PITTSBURGH,CTR BRAIN BEHAV & IMMUN,PITTSBURGH,PA
[3] CARNEGIE MELLON UNIV,PITTSBURGH,PA 15213
关键词
CEREBRAL ASYMMETRY; HANDEDNESS; ELISA; INTERLEUKIN-6; AUTOIMMUNITY;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serum interleukin-6 (IL-6) was measured in picograms/ml (pg/ml) using an immunoassay (ELISA) in healthy individuals (n = 148), of whom 128 were classified as dextral and 20 as non-dextral, as per a laterality questionnaire. Only 3 (15%) non-dextral individuals had serum IL-6 levels above the lower limit of the assay sensitivity as compared to 59 (46%) of dextral individuals (P < 0.013). There were no significant correlations between previously determined mitogen stimulated interleukin-2 production and autoantibodies in a subset of the same individuals. While this data does not provide casual information, it adds to the evidence of the asymmetric regulation of immune functions by the cerebral hemispheres.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 50 条
  • [41] Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis
    Mastorakos, G
    Ilias, I
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2000, 59 : 75 - 79
  • [42] Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery
    Vladimír Procházka
    Lukáš Lacina
    Karel Smetana
    Martin Svoboda
    Kateřina Skřivanová
    Miroslava Beňovská
    Jiří Jarkovský
    Leoš Křen
    Zdeněk Kala
    World Journal of Surgical Oncology, 21
  • [43] The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane
    Schuster, B
    Meinert, W
    Rose-John, S
    Kallen, KJ
    FEBS LETTERS, 2003, 538 (1-3) : 113 - 116
  • [44] Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
    Mahmood, Saad B. Z.
    Majid, Hafsa
    Arshad, Ainan
    Zaib-Un-Nisa, Noureen
    Niazali, Noureen
    Kazi, Kulsum
    Aslam, Aashir
    Ahmed, Sibtain
    Jamil, Bushra
    Jafri, Lena
    CLINICAL LABORATORY, 2023, 69 (06) : 1126 - 1133
  • [45] Incidence of apoptosis and cell proliferation in multiple myeloma - Correlation with bcl-2 protein expression and serum levels of interleukin-6 (IL-6) and soluble IL-6 receptor
    Chaidos, AI
    Bai, MC
    Kamina, SA
    Kanavaros, PE
    Agnantis, NJ
    Bourantas, KL
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (02) : 90 - 94
  • [46] Interleukin-6 (IL-6) production by cytokine-stimulated human Muller cells
    Yoshida, S
    Sotozono, C
    Ikeda, T
    Kinoshita, S
    CURRENT EYE RESEARCH, 2001, 22 (05) : 341 - 347
  • [47] Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery
    Prochazka, Vladimir
    Lacina, Lukas
    Smetana Jr, Karel
    Svoboda, Martin
    Skrivanova, Katerina
    Jarkovsky, Jiri
    Benovska, Miroslava
    Kren, Leos
    Kala, Zdenek
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [48] INTERLEUKIN-6 (IL-6) AND ITS RECEPTOR - THEIR ROLE IN PLASMA-CELL NEOPLASIAS
    HIRANO, T
    INTERNATIONAL JOURNAL OF CELL CLONING, 1991, 9 (03): : 166 - 184
  • [49] Effects of Interleukin-6 (IL-6) on In Vitro Cultured Equine Chorionic Girdle Cells
    Mu, Siqin
    Shen, Yingchao
    Ren, Hong
    Ulaangerel, Tseweendolmaa
    Yi, Minna
    Zhao, Bilig
    Hao, Asiya
    Liu, Qi
    Wen, Xin
    Dugarjaviin, Manglai
    Bou, Gerelchimeg
    ANIMALS, 2025, 15 (03):
  • [50] Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?
    Wechsel, HW
    Feil, G
    Lahme, S
    Zumbragel, A
    Petri, E
    Bichler, KH
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2577 - 2581